25 July 2011
Cancer Research UK scientists are currently trialling a new method aimed at detecting Barrett's oesophagus, which puts people at higher risk of oesophageal cancer diagnosis.
Barrett's oesophagus puts people at a much higher risk of developing the deadly cancer, however the cytosponge method could help identify people likely to develop the disease, so they can be offered cancer treatment.
The test involves people swallowing a small capsule with a string attached, which expands to form a small sponge in the stomach. This is then gently drawn back out and sent for testing to see if there are any signs of cancer in the cells lining the oesophagus.
Chief investigator Dr Rebecca Fitzgerald said: "If this trial is successful it will provide a cheap, safe and highly effective method of identifying people with Barrett's oesophagus, so they can take steps to reduce their risk of developing cancer."
It could even lead to a national screening programme like the one available for breast cancer.
According to data from Cancer Research UK, cancer of the oesophagus affects around 7,800 people each year in the UK.
Posted by Edward Bartel
1 'Sponge on a string' trial launched to try and prevent deadly oesophageal cancer, Cancer Research UK, Monday 25 July 2011
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.